Fund detail
Baillie Gifford
large-active, growth, lo
Quarters
52
2024-12-31
$130.14B
Positions
271
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
Price is the latest implied close from the selected quarter's 13F (value ÷ shares). Est. Cost is a running average that assumes each quarter's trades cleared near the midpoint of consecutive 13F closes (or yfinance VWAP when available). Most accurate for slow accumulators, least accurate for activists who build positions in a few days.
| # | Issuer | Value ↓ | Weight | Shares | Share Δ | Share Δ % | Prev Weight | First Held | Price | Est. Cost | Unrealized % | Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 10X Genomics Inc Class A | $0 | 0 | -40,378 | -100.00% | 0.00% | ||||||
| 2 | Alector Inc | $0 | 0 | -78,835 | -100.00% | 0.00% | ||||||
| 3 | Ascendis Pharma ADR 1:1 | $0 | 0 | -21,403 | -100.00% | 0.00% | ||||||
| 4 | BCE Inc | $0 | 0 | -31,257 | -100.00% | 0.00% | ||||||
| 5 | Brookfield Renewable | $0 | 0 | -418,371 | -100.00% | 0.01% | ||||||
| 6 | CRISPR Therapeutics AG | $0 | 0 | -364,768 | -100.00% | 0.01% | ||||||
| 7 | Exscientia Ltd ADR | $0 | 0 | -3,848,276 | -100.00% | 0.01% | ||||||
| 8 | Health Catalyst Inc | $0 | 0 | -121,855 | -100.00% | 0.00% | ||||||
| 9 | Intel Corporation | $0 | 0 | -700 | -100.00% | 0.00% | ||||||
| 10 | Ionis Pharmaceuticals | $0 | 0 | -39,581 | -100.00% | 0.00% | ||||||
| 11 | Lyell Immunopharma Inc | $0 | 0 | -141,949 | -100.00% | 0.00% | ||||||
| 12 | Mettler-Toledo | $0 | 0 | -97,005 | -100.00% | 0.11% | ||||||
| 13 | ResMed | $0 | 0 | -15,500 | -100.00% | 0.00% | ||||||
| 14 | Vir Biotechnology Inc | $0 | 0 | -2,383,029 | -100.00% | 0.01% | ||||||
| 15 | Zuora Inc Class A | $0 | 0 | -2,454,747 | -100.00% | 0.02% |